Roche India partners with Punjab Government to launch ‘NeuroSakhi’
In a landmark step toward strengthening neurological care, the Government of Punjab and Roche Pharma India have launched…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Multiple Sclerosis
Climate change to drive growth in multiple sclerosis market: GlobalData
Climate change-related exacerbations of MS will necessitate the development of more effective DMTs as disease flare ups become…
IIT Kanpur study unveil insights into working mechanism of cholesterol lowering drugs
The research has the potential to lead to the development of new drugs to lower cholesterol with fewer side effects
Multiple sclerosis market to generate sales of $29.8 bn by 2030: GlobalData
Tolebrutinib is expected to be the leading BTK inhibitor by 2030, with forecasted sales of approximately $2.6B across the 7MM
US FDA nod for Ocrevus (ocrelizumab) shorter 2-hour infusion for relapsing and primary progressive…
Approval based on data from the randomised, double-blind ENSEMBLE PLUS study, showing consistent safety to the conventional…
Zydus Cadila gets US FDA approval for fingolimod capsules and verapamil hydrochloride injection
Fingolimod is an immunomodulating drug to treat multiple sclerosis and Verapamil injection is restore normal heartbeats in people…
US FDA approves Zydus Cadila’s dimethyl fumarate DR capsules
These tablets will be manufactured at the group’s manufacturing facility at the SEZ, Matoda
Cipla gets US FDA approval for dimethyl fumarate DR capsules
It is indicated for the treatment of relapsing forms of multiple sclerosis
US FDA approves Novartis Kesimpta (ofatumumab) for relapsing forms of MS treatment
Ofatumumab was first approved by the FDA in 2009 for the treatment of chronic lymphocytic leukaemia (CLL)
Mylan announces launch of generic version of Biogen’s Tecfidera
Dimethyl fumarate delayed-release capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS)